We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin To Treat COVID-19

News   May 15, 2020 | Original story from the National Institutes of Health

 
NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin To Treat COVID-19
 
 
Advertisement
 

RELATED ARTICLES

Food Ingredient Sesaminol Alleviates Parkinson’s Symptoms in Mice

News

Researchers have discovered that the waste from sesame seed oil production has an abundance of a chemical called sesaminol, which has protective effects against Parkinson's disease.

READ MORE

Drug Designed To Treat Cancers Associated With Epstein–Barr Virus

News

Epstein-Barr virus (EBV) has infected more than 90% of the human population worldwide. EBV is known to play a key role in several cancers such as nasopharyngeal carcinoma. A research team has developed a novel drug that could become a next-generation treatment for cancers associated with EBV.

READ MORE

A New Nanotechnology-Based COVID-19 Vaccine Candidate

News

Researchers from Cleveland Clinic’s Global Center for Human Health & Pathogen Research have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE